中医药研究论丛

25S.1 新型冠状病毒肺炎重症会诊病例报告两则
TJ TCM.25(S) : 1-12, 2022
新型冠状病毒肺炎重症会诊病例报告两则
Traditional Chinese Medicine Consultation
of Severe Coronavirus Disease 2019: Two Case Reports
张馨予1 谢琼慧1 黄建荣1 陈炜达1*
1 台北市立联合医院中兴院区,台北,台湾
【摘要】
新型冠状病毒肺炎(COVID-19)自2019 年12 月至今在全球引起大流行,台湾至2021 年12 月止亦确诊达1 万6 千多人,因5 月份起的一波疫情流行导致死亡人数突破8 百例。本文报告疫情流行当时於本院收治住院的两个重症病例,两例於住院期间除接受瑞德西韦(Remdesivir)疗程外,亦同时要求中医会诊。透过中医的诊察,判断两例证型皆属湿热蕴肺、邪伏膜原之证,采宣肺清热利湿、透达膜原方法治疗後,两例皆在服用中药7 日内病情稳定且PCR 采检阴性或Ct 值30,符合解除隔离条件,而於第8 日出院返家。两例皆疗效显着,故撰本文予以探讨。
【关键词】新型冠状病毒、新型冠状病毒肺炎、新型冠状病毒肺炎重症、湿热蕴肺、宣肺清热利湿
 
Hsin-Yu Chang1 Chiung-Hui Hsieh1 Chien-Jung Huang1 Wei-Da Chen1*
1Department of Chinese Medicine, Taipei City Hospital, Zhong-Xing Branch, Taipei, Taiwan
【Summary】
The Coronavirus Disease 2019 (COVID-19) has caused a pandemic since December 2019, and more than 16,000 people have been diagnosed with COVID-19 in Taiwan as of December 2021. A wave of outbreaks in May caused more than 800 deaths. In this report, we present two severe COVID-19 inpatients in our hospital during the epidemic who not only underwent Remdesivir treatment during the hospitalization, but also receiving Traditional Chinese medicine (TCM) consultation. Through the diagnosis of TCM, the two cases are both categorized into the syndromes of damp-heat accumulating in the lungs and pathogen hiding in the pleurodiaphragmatic interspace. After treatment with dispersing lung, eliminating damp-heat and removing pathogens in pleurodiaphragmatic interspace therapy, both cases came stable within 7 days of taking TCM and had a negative PCR test or a Ct value 30. They were both eligible for release from quarantine and discharged on the 8th day after taking TCM. Here we provide these two successful experiences to suggest that dispersing lung, eliminating damp-heat and eliminating pathogens in pleurodiaphragmatic interspace therapy may be effective and applicable for COVID-19 treatment.
【Keywords】SARS-CoV-2; Coronavirus Disease 2019; damp-heat accumulating in
the lungs; dispersing lung; eliminating damp-heat